Latest News
All Times Eastern
- ‘It’s caused a lot of tension in our marriage’: My wife’s family comes visit, hides food and never cleans up. How do we get rid of them?
- Barron's China’s AI Clout Might Be Overstated. What to Know.
- Barron's This Company Makes Costco and Amazon’s Store Brands. Its Stock Is a Buy.
- Barron's This Carbon-Capture Stock Has Big Plans. Why It’s a Buy.
- Barron's Forget Apple and Nvidia. Why June Belongs to Small-Caps.
- Barron's Market Gains as Wall of Worry Crumbles. What Happens Next.
- Judge in FTX bankruptcy rejects media challenge, says customer names can remain secret
- Barron's Commercial Traders Are Net Long Copper. That’s a Good Sign for the Red Metal.
- Mark Zuckerberg says Meta may be ‘primary beneficiary’ of Apple Vision Pro headset
- Biogen stock rallies after full-day halt as FDA panel recommends Alzheimer’s drug for approval
to be replaced
Revvity Inc.
RVTYUS
$
-4.37
-3.93%
After Hours
$
106.72
After Hours Volume:
6.53K
| Close | Chg | Chg % |
|---|---|---|
| $111.09 | -0.36 | -0.32% |
Volume: 606.29K
65 Day Avg: 790.96K
110.75
Day Range
113.00
110.75
52 Week Range
170.00
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
RVTY Overview
Key Data
- Open $112.00
- Day Range 110.75 - 113.00
- 52 Week Range 110.75 - 170.00
- Market Cap $13.98B
- Shares Outstanding 125.44M
- Public Float 124.96M
- Beta 0.92
- Rev. per Employee $201.05K
- P/E Ratio 14.70
- EPS $7.56
- Yield 0.25%
- Dividend $0.07
- Ex-Dividend Date Jul 20, 2023
- Short Interest 3.33M 05/31/23
- % of Float Shorted 2.66%
- Average Volume 790.96K
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 17
Full Ratings
Stocks That Hit 52-Week Lows On Thursday
on Benzinga.com
Citi Reaffirms Their Buy Rating on Revvity (RVTY)
on TipRanks.com
PerkinElmer Completes Transformation to Become Revvity
PerkinElmer Completes Transformation to Become Revvity
on GuruFocus.com
Revvity Inc.
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Danaher Corp. | $173.71B | |
| IDEXX Laboratories Inc. | $37.6B | |
| Agilent Technologies Inc. | $33.88B | |
| Mettler-Toledo International Inc. | $28.53B | |
| Ametek Inc. | $34.67B | |
| Fortive Corp. | $24.18B | |
| Waters Corp. | $14.76B | |
| Teledyne Technologies Inc. | $18.67B | |
| Hologic Inc. | $19.24B | |
| Dentsply Sirona Inc. | $8.23B |